Association between Patient Experience and Medication Compliance of Dyslipidemia: Using Korea National Health and Nutrition Examination Survey (2015)

Korean Journal of Family Medicine 2021³â 42±Ç 2È£ p.116 ~ p.122

ÀÓÈ£Çö(Yim Ho-Hyoun) - Hanyang University College of Medicine Department of Family Medicine
Ȳȯ½Ä(Hwang Hwan-Sik) - Hanyang University College of Medicine Department of Family Medicine
¹ÚÈƱâ(Park Hoon-Ki) - Hanyang University College of Medicine Department of Family Medicine
¹Ú°è¿µ(Park Kye-Yeung) - Hanyang University College of Medicine Department of Family Medicine
¹Ú¹Ì¼Ò(Park Mi-So) - Hanyang University College of Medicine Department of Family Medicine

Abstract

Background: This study aimed to examine the relationship between patient experience and medication compliance of patients with dyslipidemia.

Methods: Based on data from the Korea National Health and Nutrition Examination Survey in 2015, the study examined 764 patients treated with dyslipidemia medication. Subjects who responded to the question ¡°Do you currently take medication to lower your blood cholesterol?¡± with ¡°daily taking¡± were categorized as the compliant group, and the remaining subjects were classified under the non-compliant group. The patient experience survey included four indicators, in which subjects were divided into groups with a positive and negative patient experience. Data on sociodemographic factors, health-related behaviors, and self-reported comorbid conditions were also collected.

Results: After adjusting the variables, the group with a positive response for the patient experience indicator ¡°doctor spends enough time with the patient during consultation¡± was 1.89 times more compliant than the group with a negative response (95% confidence interval [CI], 1.03?3.48; P=0.04). For the indicator ¡°doctor provides easy-to-understand explanations,¡± the group that showed a positive response was 2.74 times more compliant than the group with a negative response (95% CI, 1.39?5.39; P=0.004). For the indicator ¡°doctor involves patients in decisions about care or treatment,¡± the group that showed a positive response was 2.07 times more compliant than the group with a negative response (95% CI, 1.02?4.22; P=0.04). However, for the indicator ¡°doctor provides the patient a chance to ask questions about treatment,¡± positive patient experience had no significant association with medication compliance (95% CI, 0.77?2.36; P=0.30).

Conclusion: Building a good doctor-patient relationship with positive patient experiences can result in better outcomes for patient care through high medication compliance.

Å°¿öµå

Dyslipidemias, Compliance, Medication Adherence, Patient Experience, Patient-Centered Care
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This study reported that positive patient experience was associated with better medication compliance in patients with dyslipidemia.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå